Learning Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Types and Uses of Various SARS-CoV-19 Tests

    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 10/07/2020 at 1:00 PM (EDT)

    The novel coronavirus (SARS-CoV-19) was first identified in Wuhan, China in December 2019. Since that time, it has rapidly spread across the globe. To help combat the epidemic, multiple testing techniques have been developed. Such technologies include molecular and diagnostic assays which detect active infection as well as antibody tests that may identify if a person has been previously exposed to the virus. In this webinar the process and science of the various testing strategies will be discussed as well as a look toward future testing techniques.

    The novel coronavirus (SARS-CoV-19) was first identified in Wuhan, China in December 2019. Since that time, it has rapidly spread across the globe.  To help combat the epidemic, multiple testing techniques have been developed.  Such technologies include molecular and diagnostic assays which detect active infection as well as antibody tests that may identify if a person has been previously exposed to the virus.  In this webinar the process and science of the various testing strategies will be discussed as well as a look toward future testing techniques.

    Learning Objectives:

    • Differentiate between diagnostic and antibody tests for SARS-CoV-19.
    • Describe the differences, pros, and cons between a nucleic acid and antigen diagnostic test.
    • Given a patient case, identify the best SARS-CoV-19 test to use.

    Stephanie James, PhD, MBA

    Associate Professor of Pharmaceutical Science, Regis University School of Pharmacy

    Dr. Stephanie James is an Associate Professor of Pharmaceutical Science in the Regis University School of Pharmacy, where she teaches the immunology and infectious disease units.  She is also the current laboratory director of the Regis University Pharmacy testing lab where she processes and tests patient samples for coronavirus.  Dr. James earned her PhD in Biological Education from the University of Northern Colorado and completed a postdoctoral fellowship at the University of Colorado School of Medicine.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 7, 2023

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • What’s Bugging You? A Review of Antibiotic Infusion Therapy

    Contains 3 Component(s), Includes Credits Recorded On: 09/23/2020

    Treatment of complicated infections with intravenous antibiotics has largely transitioned to the outpatient setting due to inpatient costs and improved patient satisfaction. Infusion nurses are crucial in the management of patient symptoms, antibiotic adverse effects, and appropriate monitoring in all settings. This webinar will cover the key components of antimicrobial selection and monitoring, including adverse effects. In addition, some new antimicrobial therapies will also be reviewed.

    Treatment of complicated infections with intravenous antibiotics has largely transitioned to the outpatient setting due to inpatient costs and improved patient satisfaction. Infusion nurses are crucial in the management of patient symptoms, antibiotic adverse effects, and appropriate monitoring in all settings. This webinar will cover the key components of antimicrobial selection and monitoring, including adverse effects. In addition, some new antimicrobial therapies will also be reviewed.

     

    Learning Objectives

    ·       Describe factors involved in antimicrobial selection for treatment of complicated infections including:

              o   Indication

              o   Antimicrobial spectrum

              o   Dosing considerations

    ·       Verbalize adverse effects and monitoring for commonly used antibiotic infusions

    ​Amber Streifel, PharmD

    Outpatient Parenteral Antimicrobial Therapist/OPAT pharmacist, Oregon Health & Science University

    Amber Streifel, PharmD is the Outpatient Parenteral Antimicrobial Therapist/OPAT pharmacist at Oregon Health & Science University. She earned her PharmD at the University of Maryland, Baltimore. She completed her PGY1 pharmacy residency at OHSU and her PGY2 in Infectious Diseases at the University of Colorado, Denver.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 23, 2023

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Episode 68: August 19, 2020 - Looking ahead to INS 2020 Virtual!

    Contains 1 Component(s)

    Join us, as we highlight the many things to look forward to at INS 2020 Virtual!

    Join us, as we highlight the many things to look forward to at INS 2020 Virtual!

    Sean Reed, PhD, APN, ACNS-BC, ACHPN

    Clinical Nurse Specialist in Adult Health, Hospice and Palliative Care

    Sean M. Reed, PhD, APN, ACNS-BC, ACHPN, is a Clinical Nurse Specialist in Adult Health, Hospice and Palliative Care. He has over 15 years of experience in acute, post-acute, ambulatory, systems, and academic settings. Dr. Reed is currently an Assistant Professor at the University of Colorado, College of Nursing, where he teaches and researches delivery and access to palliative care. He is the President of the National Association of Clinical Nurse Specialists.

    Sarah Knudsvig, RN

    Registered Nurse Clinical Staff Educator, UW Health in Madison, WI

    Sarah Knudsvig, RN, MSN, is a Registered Nurse Clinical Staff Educator at UW Health in Madison, WI. She is an organizational resource for vascular access care, maintenance, and insertion for clinical staff across 135 ambulatory sites. Sarah holds a Bachelor of Science in Nursing from the University of Mary in Bismarck, North Dakota and a Master of Science in Nursing from Benedictine University in Lisle, Illinois.

    ​Judy S. Smith, MSN, RN, CRNI®, VA-BC

    Clinical Manager of Vascular Access, Ascension Seton

    Judy S. Smith, MSN, RN, CRNI®, VA-BC, has been a vascular access nurse for 20 years. She is currently Clinical Manager of Vascular Access at Ascension Seton in Austin, Texas. Judy has published studies on nurse behavioral intention, related to best practice techniques for needleless connector disinfection, as well time required for disinfection of needleless connectors. She has been a speaker at several local and national conferences and served as keynote speaker at Intravenous Nursing New Zealand in 2012. 

    Linda Grinnell Merrick, NP-C

    Rheumatology NP, University of Rochester Medical Center

    Linda Grinnell-Merrick, MS, NP-C, is a Rheumatology NP at the University of Rochester Medical Center in Rochester, NY. Prior to this, she worked in Solid Organ Transplant for 15 years as NP. She is a past president of the Rheumatology Nurses Society. Linda has written many articles for the RNP (Rheumatology Nurse Practice) Newsletter and is the Editor of Healio Rheumatology. She has spoken at RNS annual conference and the NYU Annual Psoriasis and Psoriatic Arthritis conference, as well as other conferences on rheumatology.

    Denise Harper, MSN, RN, ACNS-BC, CRNI®

    CNS, Vidant Medical Center

    Denise Harper, MSN, RN, ACNS-BC, CRNI®, has been the Infusion Clinical Nurse Specialist at Vidant Medical Center since 2010. She has over 30 years of experience, including home infusion and various roles in acute care. Denise is a former member of the INS NCOE and was selected into The Great 100 Nurses in NC for 2015. She has published several articles locally and nationally and has delivered podium presentations throughout the country.

    Ann Plohal, PhD, RN, ACNS-BC, CRNI®, VA-BC

    Vascular Access Team, St. Joseph Hospital Medical Center

    Dr. Ann Plohal, PhD, RN, ACNS-BC, CRNI®, VA-BC, is a member of the vascular access team at St. Joseph Hospital Medical Center and Barrow Neurological Institute in Phoenix, Arizona. She is past president of the Infusion Nurses Society (2014-2015). She has written and presented multiple topics related to vascular access and infusion therapy. Dr. Plohal’s hands on experience gives her a unique perspective on vascular access and embolism.

    Julie DeLisle, BSN, MSN, RN

    Transfusion Safety & Blood Management Officer, Versiti Blood Center of WI

    Julie DeLisle, BSN, MSN, RN, is a Transfusion Safety and Blood Management Officer at Versiti Blood Center of WI. She received her Bachelor of Nursing at University of WI Oshkosh and Master of Nursing Education at Cardinal Stritch University. Julie started her career in Oncology. She has published several articles and authored chapters in books. She currently works to ensure that healthcare providers and patients are educated on evidence-based transfusion practice.

    Marlene Steinheiser, PhD, RN, CRNI®

    Director of Clinical Education, INS

    Marlene Steinheiser, PhD, RN, CRNI®, is the Director of Clinical Education for INS. In her role, she directs the development of educational programs and resources for INS and develops strategic alliances with other organizations. She earned her PhD in nursing at the University of Arizona, conducting research focusing on compassion fatigue among healthcare professionals. A nurse for more than 32 years, Dr. Steinheiser has had experience in acute care, home infusion, long-term care, regulatory organizations, and academic nursing.

    Meghan Trupiano, CMP

    Meetings Manager, INS

    As INS’ meetings manager, Meghan Trupiano, CMP, manages all activities related to INS’ national meetings. She is responsible for exhibit space sales, advertising, and sponsorship sales, as well as attendee marketing.

    Host: Dawn Berndt, DNP, RN, CRNI® – INS Clinical Education & Publications Manager

    Guests:

    ·      Sean M Reed, PhD, APN, ACNS-BC, ACHPN

    ·      Sarah Knudsvig, RN

    ·      Judy Smith, MSN, RN, CRNI®, VA-BC

    ·      Linda Grinnell Merrick, MS, NP-C

    ·      Denise Harper, MSN, RN, ACNS-BC, CRNI®

    ·      Ann Plohal, PhD, RN, ACNS-BC, CRNI®, VA-BC

    ·      Julie DeLisle, BSN, MSN, RN

    ·      Marlene Steinheiser, PhD, RN, CRNI®

    ·      Meghan Trupiano, CMP

    Join us, as we highlight the many things to look forward to at INS 2020 Virtual! We will chat with Meaghan Trupiano, CMP, INS Meetings Manager, who will tell us what we need to know about this unique and engaging event. INS Director of Clinical Education, Marlene Steinheiser, PhD, RN, CRNI®, will get us ready for a fun and poignant presentation by the founder of our profession, Florence Nightingale, who will be channeled by Candy Campbell, DNP, RN, CNL, CEP, FNAP. We will also talk with several of our featured speakers, who will preview their upcoming sessions.

    Resources:

    Infusion Nurses Society: www.ins1.org

    INS 2020 Conference Agenda: https://fontevacustomer-1614e2ff498.force.com/s/lt-event?site=a0d3m00000INxmkAAD&id=a1U3m00000NTdgt#/Agenda

     

    Register for INS 2020: https://fontevacustomer-1614e2ff498.force.com/s/lt-event?site=a0d3m00000INxmkAAD&id=a1U3m00000NTdgt#/loginReg

     

    INS 2020 Speakers: https://fontevacustomer-1614e2ff498.force.com/s/lt-event?site=a0d3m00000INxmkAAD&id=a1U3m00000NTdgt#/Speakers

  • Utilizing Data to Inform Decision Making in a Pandemic and Shape Future Practices

    Contains 3 Component(s), Includes Credits Recorded On: 08/12/2020

    The SARS-CoV-2 virus that causes COVID-19 has disrupted life as we know it, including how we practice and deliver healthcare. During this unprecedented time, it is critical to utilize data to inform decision making and future practices. Data collection and analysis have critical roles in shaping programs, tracking progress, evaluating results, demonstrating accountability, and informing policies that will improve plans for future events. This presentation will take you through an historic journey covering several pandemics and will showcase how data collection and research significantly contributed to informed decision making. We will explore the importance of both qualitative and quantitative research, various data sources, and data reporting limitations, as well as opportunities to affect change during this pandemic and well into the future.

    The SARS-CoV-2 virus that causes COVID-19 has disrupted life as we know it, including how we practice and deliver healthcare. During this unprecedented time, it is critical to utilize data to inform decision making and future practices. Data collection and analysis have critical roles in shaping programs, tracking progress, evaluating results, demonstrating accountability, and informing policies that will improve plans for future events. This presentation will take you through an historic journey covering several pandemics and will showcase how data collection and research significantly contributed to informed decision making. We will explore the importance of both qualitative and quantitative research, various data sources, and data reporting limitations, as well as opportunities to affect change during this pandemic and well into the future.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    •       Discuss the importance of data collection during a pandemic

    •       Review the importance of both qualitative and quantitative research.

    •       Explore how data drives informed decision-making.

    •       Review current COVID-19 data reporting limitations and opportunities.

    Buffy Lloyd-Krejci

    Founder, Lloyd-Krejci Consulting

    Founder Dr. Buffy Lloyd-Krejci has always had a passion for mitigating infectious diseases through a data-driven approach. Utilizing her degrees in Applied Mathematics and Bio-Medical Informatics, she participated in a national CDC and CMS pilot study supporting long-term care facilities in enrolling and reporting Clostridioides difficile infection into NHSN. Buffy realized how infections impact this vulnerable patient population with national estimates of 1-3 million infections leading to 380,000 deaths every year. Drawn to action to improve the infection prevention landscape, she founded Lloyd-Krejci Consulting.  

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 12, 2023

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Episode 67: August 5, 2020 - Vascular Access Team: Managing Challenges Associated with COVID-19

    Contains 1 Component(s)

    Vascular access team members discuss challenges during the COVID-19 Pandemic.

    Vascular access team members discuss challenges during the COVID-19 Pandemic.

    Elizabeth Morrell, DNP, RN, NEA-BC

    Scripps Mercy Hospital

    Elizabeth Morrell, DNP, RN, NEA-BC, is senior director of patient care at Scripps Mercy Hospitals where she has dual campus leadership responsibility for venous access nurses, advanced practice nurses and interventional radiology, along with cardiac and endoscopy services. Elizabeth also currently serves as the COVID-19 operations chief for the San Diego campus in Hillcrest. 

    Patti Ryan, MSN, RN

    Scripps Mercy Hospital

    Patti Ryan, MSN, RN, has been an RN for over 43 years. She received her Diploma is Nursing from Butterworth Hospital School of Nursing in 1977 and her BSN from University of San Diego in 1989. She earned her MSN, Family Health CNS, in 1993. Patti has eclectic work experience including US Navy, pediatrics, neonatal, oncology, CNS, and home health. She has been employed at Scripps Mercy Hospital in San Diego, CA since 2001 and a member of the Vascular Access Team since 2004. Patti is a wife, mother of 3 and grandmother of 1. Her outside interests include RV adventures, crocheting and other handicrafts, disability advocacy.

    Marivic Guzman, BSN RN, VA-BC

    Precision Vascular Access

    Marivic has over 15 years of nursing experience, with the bulk of her career being spent in CVICU. While working in critical care, Marivic dabbled in other areas of nursing, such as a Recovery Room Nursing, teaching Clinicals at a Vocational Nursing School, facilitating megacodes for ACLS classes and getting involved in the Code Blue Committee, as well as a managerial role at an outpatient infusion center. Her experience helped her to easily transition to her new role of IV Nurse in 2014. Her plans to convert to a Vascular Access Team took place shortly thereafter, where bedside PICC placement would be a newly implemented approach to care. She helped to see through the conversion from an IV Team to a Vascular Access Team and went on to obtain her Vascular Access Board Certification. 

    In 2018, Precision Vascular Access was founded in order to address a gap in care in the local medical community. Since its inception, Precision Vascular Access has helped to close a gap in care in the outpatient world, providing all-inclusive outpatient infusion care to patients and doctors alike. 

    Host: Dawn Berndt, DNP, RN, CRNI® – INS Clinical Education & Publications Manager

    Guests:

    ·      Elizabeth Morrell, DNP, RN, NEA-BC

    ·      Patti Ryan, MSN, RN

    ·       Marivic Guzman, BSN RN, VA-BC

    In this podcast, vascular access team members discuss the challenges of practicing during the COVID-19 pandemic. Team members address changes in time management, personal protective equipment protocols, and vascular access device selection. Learn how these exceptional clinicians have worked to modify practice to accommodate changes needed during the pandemic. Explore how teamwork and collaboration across the organization has boosted morale for health care personnel.

  • Episode 66: July 23, 2020 - SHEA and INS Collaboration Podcast - Working together to address COVID-19 Challenges

    Contains 1 Component(s)

    Collaboration During COVID-19. Infusion Nurses Society in Collaboration with Society for Healthcare Epidemiology of America (SHEA). In this episode, Dr. Sara Keller and Dawn Berndt discuss a collaboration between Hospital Epidemiology and Infusion Nursing.

    Collaboration During COVID-19. Infusion Nurses Society in Collaboration with Society for Healthcare Epidemiology of America (SHEA). In this episode, Dr. Sara Keller and Dawn Berndt discuss a collaboration between Hospital Epidemiology and Infusion Nursing.

    Sara C. Keller, MD, MPH, MSHP

    Assistant Professor of Medicine Infection Disease, Johns Hopkins University School of Medicine

    Sara C. Keller, MD, MPH, MSHP, is an Assistant Professor of Medicine in the Division of Infectious Disease at Johns Hopkins University School of Medicine. She is also Associate Faculty in the Armstrong Institute of Patient Safety and Quality at the Johns Hopkins University School of Medicine. Dr Keller's research interests focus on improving the quality of care of patients receiving parenteral antibiotics outside the hospital, measures and outcomes among patients with central venous catheters in the home, and improving ambulatory antimicrobial stewardship. 

    Dawn Berndt, DNP, RN, CRNI®

    Clinical Education & Publications Manager, INS

    Dawn serves as INS’ Clinical Education and Publications Manager. She has been an active INS member and a CRNI® since 2005. She served on INS’ National Council on Education from 2011 to 2014 and on INS’ Board of Directors as a Director-at-Large from 2017 to 2018. Prior to joining the INS team, Dawn worked for 13 years as a clinical nurse specialist for infusion and as nurse manager of the infusion center, the venous access team, and the RN response team at the University of Wisconsin Health - University Hospital. Dawn holds a doctor of nursing practice in clinical leadership from the Henry Predolin School of Nursing at Edgewood College in Madison, Wisconsin; a master’s of nursing education from the University of Wisconsin School of Nursing; and a bachelor’s degree in nursing from the University of Phoenix in Phoenix.

    Guests: 
    • Sara Keller, MD, MPH, MSHP – Moderator
    • Dawn Berndt, DNP, RN, CRNI® 

    Abstract: 
    We’re all in this Together: COVID-19 Allies in Infection Prevention
    We’ve joined the Society for Healthcare Epidemiology of America (SHEA) for an episode of their Allies in Infection Prevention Podcast. This podcast series focuses on collaborative efforts, as well as opportunities for different disciplines to address and confront the COVID-19 pandemic.
    Take a listen to Working together to address COVID-19 Challenges.

    Resources:
    Society for Healthcare Epidemiology of America (SHEA). https://www.shea-online.org/ 
    Infusion Nurses Society (INS). www.ins1.org 

  • Pandemic Perspectives: Placing COVID-19 in Historical Context

    Contains 3 Component(s), Includes Credits Recorded On: 07/15/2020

    PANDEMIC: Prevalence in an entire country or the world. Historical records indicate infectious diseases have reached pandemic proportions throughout history, each affecting thousands, even millions of people across the globe. The coronavirus (COVID-19), now listed among other notorious diseases, has impacted 216 countries or territories and has infected more than 9 million people. This webinar presents COVID-19 within an historical context and includes a review of viral and bacterial infection and transmission.

    PANDEMIC: Prevalence in an entire country or the world. Historical records indicate infectious diseases have reached pandemic proportions throughout history, each affecting thousands, even millions of people across the globe. The coronavirus (COVID-19), now listed among other notorious diseases, has impacted 216 countries or territories and has infected more than 9 million people. This webinar presents COVID-19 within an historical context and includes a review of viral and bacterial infection and transmission. 

    Learning Outcomes:
    At the conclusion of this webinar, learners will be able to: 
    1) Recognize COVID-19 in relation to other notable pandemic diseases
    2) Describe the differences between viral and bacterial infection
    3) List common types of transmission and transmission prevention 

    Dawn Berndt, DNP, RN, CRNI®

    Clinical Education & Publications Manager, INS

    Dawn serves as INS’ Clinical Education and Publications Manager. She has been an active INS member and a CRNI® since 2005. She served on INS’ National Council on Education from 2011 to 2014 and on INS’ Board of Directors as a Director-at-Large from 2017 to 2018. Prior to joining the INS team, Dawn worked for 13 years as a clinical nurse specialist for infusion and as nurse manager of the infusion center, the venous access team, and the RN response team at the University of Wisconsin Health - University Hospital. Dawn holds a doctor of nursing practice in clinical leadership from the Henry Predolin School of Nursing at Edgewood College in Madison, Wisconsin; a master’s of nursing education from the University of Wisconsin School of Nursing; and a bachelor’s degree in nursing from the University of Phoenix in Phoenix.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 15, 2023

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

  • Episode 65: July 10, 2020 - Promoting Excellence in Infusion Nursing Through CRNI® Certification

    Contains 1 Component(s)

    Make an impact: Validate your expertise in the infusion therapy specialty through CRNI® certification.

    Make an impact: Validate your expertise in the infusion therapy specialty through CRNI® certification.

    Adrienne Segundo

    Certification Manager, INCC

    Adrienne is the Certification Manager for the Infusion Nurses Certification Corporation (INCC). She is responsible for CRNI® certification development, maintenance, and growth, as well as working with subject matter experts and INS membership volunteers toward the ongoing development of the CRNI® credential. She also ensures that certification-related activities are carried out according to accreditation standards set by the National Commission for Certifying Agencies. Adrienne has more than 19 years of association management experience, all which of which has been in certification program operations.

    Valerie Sanchez

    Certification Administrator, INCC

    Valerie is responsible for administering all tasks associated with the maintenance of the CRNI® certification program and the growth of Infusion Nurses Certification Corporation. With the rest of the team, she creates and implements innovative and engaging certification initiatives. With over a decade of experience in marketing, sales and advertising, Valerie brings a unique approach toward management and administration.  Valerie is happy to answer any questions regarding the CRNI® exam, CRNI® Academy, and the recertification process in general.

    Host: Dawn Berndt, DNP, RN, CRNI® – INS Clinical Education & Publications Manager

    Guests:

    • Adrienne Segundo, INCC Certification Manager
    • Valerie Sanchez, INCC Certification Administrator

    Abstract: 
    Are you ready to be certified? Validating your experience by becoming a Certified Registered Nurse Infusion (CRNI®) is one of the most significant decisions you can make in your infusion nursing journey. The Infusion Nurses Certification Corporation, INCC, offers the only specialty certification for infusion nurses that is nationally recognized and accredited. Listen as Adrienne Segundo, INCC Certification Manager and Valerie Sanchez, INCC Certification Administrator describe the importance of certification and learn what INCC resources are available to help you attain your goal. INCC is ready to assist you in becoming a CRNI®!


    Resources:
    • Infusion Nurses Certification Corporation: https://www.ins1.org/crni-cert... 
    • CRNI Exam Study Handbook: https://www.ins1.org/wp-conten... 
    • CRNI Study Information: https://www.ins1.org/crni-cert... 
    • CRNI Exam Basics: https://www.ins1.org/crni-cert... 
    • Frequently Asked Questions: https://www.ins1.org/crni-cert... 

  • Vascular Access Device Care and Management: A Comprehensive Organizational Approach

    Contains 1 Component(s)

    The Infusion Nurses Society asserts that a comprehensive organizational approach to vascular access device (VAD) care and management is imperative to ensure safe and efficacious patient care. It is essential that each organization (1) develops policies and procedures to align VAD care and management with recognized standards of practice; (2) integrates unique aspects of organization-selected VAD care products into policies and procedures and establishes expectations for adherence to these organizational directives; (3) develops a framework for gathering and analyzing clinical data related to patient outcomes for VAD care and management; (4) utilizes quality outcome data to facilitate evidence-based best practices within the organization; and (5) evaluates and facilitates educational programming to validate clinician competency.

    The Infusion Nurses Society asserts that a comprehensive organizational approach to vascular access device (VAD) care and management is imperative to ensure safe and efficacious patient care. It is essential that each organization (1) develops policies and procedures to align VAD care and management with recognized standards of practice; (2) integrates unique aspects of organization-selected VAD care products into policies and procedures and establishes expectations for adherence to these organizational directives; (3) develops a framework for gathering and analyzing clinical data related to patient outcomes for VAD care and management; (4) utilizes quality outcome data to facilitate evidence-based best practices within the organization; and (5) evaluates and facilitates educational programming to validate clinician competency.

  • Biosimilars in Cancer Therapy and Beyond: Implications for Nursing Practice

    Contains 3 Component(s), Includes Credits Recorded On: 06/17/2020

    This webinar will guide the participant through the brief history of biologics. We will explore the science and the advances that have been made since the first EMA-approved biosimilar, omnitropin, a recombinant human growth hormone with indications for pituitary dwarfism, Prader-Willi Syndrome, and Turner Syndrome, hit the EU market in 2006, as well as the first FDA-approved biosimilar, filgrastim-sndz hit the US market in 2015. A robust discussion on the progress of biosimilars in Europe and the US, relating to research and development, access, outcomes, cost savings, and nursing implications before, during, and after biosimilar administration are included in this webinar.

    Commerical Support: Coherus

    image

    Biosimilars are biologics, such as hormones and monoclonal antibodies, which are produced from living systems that may be sourced from nature or “genetically engineered,” AKA “biotech” products. A biosimilar is defined as a biologic product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference biologic. Biologics have revolutionized the treatment and management of many malignant diseases, such as cancer. Biosimilars provide opportunities for improving healthcare access and outcomes, as well as reducing overall healthcare costs because of their cheaper price, relative to their reference biologics. 

    This webinar will guide the participant through the brief history of biologics. We will explore the science and the advances that have been made since the first EMA-approved biosimilar, omnitropin, a recombinant human growth hormone with indications for pituitary dwarfism, Prader-Willi Syndrome, and Turner Syndrome, hit the EU market in 2006, as well as the first FDA-approved biosimilar, filgrastim-sndz hit the US market in 2015. A robust discussion on the progress of biosimilars in Europe and the US, relating to research and development, access, outcomes, cost savings, and nursing implications before, during, and after biosimilar administration are included in this webinar.

    Learning Outcomes: At the conclusion of this webinar, learners will be able to:

    o Describe the history, science and advances in biosimilar development, analytical methods, and commercialization
    o Verbalize the step-wise approach for the development of biosimilars
    o Outline the nursing implications for interchangeability and substitution issues concerning biosimilars
    o Summarize the FDA-approved indications of biosimilars and the nursing roles before, during, and after their administrations 

    Joseph D. Tariman, PhD, RN, ANP-BC, FAAN

    Dr. Joseph D. Tariman, PhD, RN, ANP-BC, FAAN, is the editor and author of the only myeloma nursing textbooks (1st, 2nd, and the upcoming 3rd editions), author of eight myeloma book chapters, 18 conference abstracts, and 72 PubMed-indexed, peer-reviewed papers. He has given hundreds of presentations on topics affecting myeloma nursing practice, including the use of biosimilars, at local, regional, national and international conferences. He is currently an associate editor for the Clinical Journal of Oncology Nursing through June 2020.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 17, 2023

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.